ScholarIQanswers from OpenAlex
Centre Hospitalier de l’Université de Montréal
InstitutionResearch output, impact & collaborations
Centre Hospitalier de l’Université de Montréal is a institution indexed in ScholarIQ from OpenAlex.
What is known about Centre Hospitalier de l’Université de Montréal?
ScholarIQrecord summary
Centre Hospitalier de l’Université de Montréal is a research organisation in Montreal, CA. OpenAlex records 19,386 works and 1,803,854 citations for it. 4,727 researchers list it as their most recent affiliation.
How many works does Centre Hospitalier de l’Université de Montréal have?
ScholarIQindexed works
Centre Hospitalier de l’Université de Montréal has 19,386 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Centre Hospitalier de l’Université de Montréal have?
ScholarIQcitation count
Centre Hospitalier de l’Université de Montréal has 1,803,854 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Centre Hospitalier de l’Université de Montréal?
ScholarIQresearcher count
Centre Hospitalier de l’Université de Montréal has 4,727 researchers in the ScholarIQ index.
What is the average h-index at Centre Hospitalier de l’Université de Montréal?
ScholarIQavg h-index
Centre Hospitalier de l’Université de Montréal has an average h-index of 54.2 in OpenAlex.
What is the ROR of Centre Hospitalier de l’Université de Montréal?
ScholarIQror
The ROR for Centre Hospitalier de l’Université de Montréal is on the source record.
What is the OpenAlex record for Centre Hospitalier de l’Université de Montréal?
ScholarIQopenalex
The OpenAlex for Centre Hospitalier de l’Université de Montréal is on the source record.
Who are the most-cited researchers behind Centre Hospitalier de l’Université de Montréal?
ScholarIQtop researchers by citations
5
Michel Boivin · Child and Adolescent Psychosocial and Emotional Development
732 works29,553 citationsWhat are the most-cited papers on Centre Hospitalier de l’Université de Montréal?
ScholarIQmost cited works
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
The ADVANCE Collaborative Group
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, Carol Redmond, Maureen Kavanah, Walter M. Cronin, Victor G. Vogel, André Robidoux, Nikolay Dimitrov, James N. Atkins, Mary B. Daly, Samuel Wieand, Elizabeth Tan-Chiu, Leslie G. Ford, Norman Wolmark, other National Surgical Adjuvant Breast, Bowel Project Investigators
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett Hughes, Ricard Mesı́a, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Ruey‐Long Hong, René González Mendoza, Ananya Roy, Yayan Zhang, Burak Gümüşçü, Jonathan D. Cheng, Fan Jin, Danny Rischin, Guillermo Lerzo, Marcelo Tatangelo, Mirta Varela, Juan José Zarbá, Michael Boyer, Hui Gan, Bo Gao, Brett Hughes, Girish Mallesara, Danny Rischin, Anne L. Taylor, Martin Burian, Thorsten Fuereder, Richard Greil, Carlos H. Barrios, Dalvaro Oliveira de Castro Junior, Gilberto de Castro, Fábio Franke, Gustavo Girotto, Iane Pinto Figueiredo Lima, Ulisses Ribaldo Nicolau, Gustavo Dix Junqueira Pinto, Lucas Vieira dos Santos, Ana-Paula Victorino, Neil Chua, Félix Couture, Richard Gregg, Aaron R. Hansen, John Hilton, Joy McCarthy, Denis Soulières, Rodrigo Ascuí, Pablo Gonzalez, Luis J. Villanueva-Rivera, Marco Torregroza, Ángela R. Zambrano, Petra Holečková, Zdeněk Král, Bohuslav Melichar, Prausova Jana, Milan Vošmik, Maria Andersen, Niels Gyldenkerne, Hannes Jürgens, Kadri Putnik, Petri Reinikainen, Viktor Gruenwald, Simon Laban, Gerasimos Aravantinos, Ioannis Boukovinas, Vassilis Georgoulias, Amanda Psyrri, D.L.W. Kwong, Yousuf Al-Farhat, Tibor Csőszi, József Erfán, Geza Horvai, László Landherr, Éva Remenár, Ágnes Ruzsa, Judit Szota, Salem Billan, Iris Gluck, Orit Gutfeld, Aron Popovtzer, Marco Benasso, Simona Bui, Vittorio Ferrari, Lisa Licitra, Franco Nolè, Takashi Fujii, Yasushi Fujimoto, Nobuhiro Hanai, Hiroki Hara, Koji Matsumoto, Kenji Mitsugi
A genome-wide association study identifies novel risk loci for type 2 diabetes
Robert Sladek, Ghislain Rocheleau, Johan Rung, Christian Dina, Li Shen, David Serre, Philippe Boutin, Daniel Vincent, Alexandre Bélisle, Samy Hadjadj, Beverley Balkau, Barbara Heude, G. Charpentier, Thomas J. Hudson, Alexandre Montpetit, Alexey V. Pshezhetsky, Marc Prentki, Barry I. Posner, David J. Balding, Stephen Eyre, Constantin Polychronakos, Philippe Froguel
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
David N. Krag, Stewart Anderson, Thomas B. Julian, Ann Brown, Seth P. Harlow, Joseph P. Costantino, Takamaru Ashikaga, Donald L. Weaver, Eleftherios P. Mamounas, Lynne M Jalovec, Thomas G. Frazier, R. Dirk Noyes, André Robidoux, Hugh MC Scarth, Norman Wolmark
How much of the research on Centre Hospitalier de l’Université de Montréal is open access?
ScholarIQopen access share
83%OPEN ACCESS